Oncofertility: does ovarian response to hormonal stimulation change with a cancer diagnosis?
نویسندگان
چکیده
منابع مشابه
Oncofertility: combination of ovarian stimulation with subsequent ovarian tissue extraction on the day of oocyte retrieval
BACKGROUND New anticancer treatments have increased survival rates for cancer patients, but often at the cost of sterility. Several strategies are currently available for preserving fertility. However, the chances of achieving a pregnancy with one technique are still limited. A combination of methods is therefore recommended in order to maximize women's chances of future fertility. In this retr...
متن کاملDoes MDR-1 G2677T/A polymorphism really associate with ovarian cancer response to paclitaxel chemotherapy?
To the Editor: In the February 1, 2006 issue of Clinical Cancer Research , Gréen et al. (1) described an association between G2677A/T single nucleotide polymorphism of MDR-1 gene and response to paclitaxel chemotherapy. The investigators state that ‘‘the probability of responding to paclitaxel treatment is higher in homozygously mutated patients (TT or TA)’’. In our opinion, there are some issu...
متن کاملI-37: Controlled Ovarian Stimulation in Cancer Patients
Recent advances in the technology of vitrification of human oocytes and embryos have increased the opportunities for fertility preservation in cancer patients. Ovarian stimulation in this group of patients is associated with some unique challenges. A controversy in this field rotated around the hypothesis that the transient elevations of estrogen during an IVF cycle may stimulate tumor growth; ...
متن کاملI-22: Fertility Preservation and Ovarian Stimulation in Cancer Patients
Cancer is not uncommon and no longer considered to be an incurable disorder. 10% of cancer cases occur under the age of 45. There is a remarkable improvement in treatment and survival rates. Today women have been delaying initiation of childbearing because the incidence of most cancers increases with age. Delayed childbearing results in more female cancer survivors. As a consequence there is an...
متن کاملAdrenergic Stimulation of DUSP1 Impairs Chemotherapy Response in Ovarian Cancer.
PURPOSE Chronic adrenergic activation has been shown to associate with adverse clinical outcomes in cancer patients, but the underlying mechanisms are not well understood. The focus of the current study was to determine the functional and biologic effects of adrenergic pathways on response to chemotherapy in the context of ovarian cancer. EXPERIMENTAL DESIGN Increased DUSP1 production by symp...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Fertility and Sterility
سال: 2019
ISSN: 0015-0282
DOI: 10.1016/j.fertnstert.2019.02.114